F-star Therapeutics, Inc. logo

F-star Therapeutics, Inc. (FSTX)

Market Closed
8 Mar, 20:00
NASDAQ (CM) NASDAQ (CM)
$
7. 12
0
0%
$
156.51M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 7.12
Previous Close
Add Transaction
Day Range
7.11 7.12
Year Range
2.07 7.12
Want to track FSTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

F-star Therapeutics, Inc. (FSTX) Statistics

Valuation metrics

Market Cap 156.51M
Enterprise value 91.2M
Trailing P/E (ttm) -3.79
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) 7.39
Price/Book (mrq) 1.22
Enterprise Value/Revenue 4.31
Enterprise Value/EBITDA -3.1

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -

Price summary

52-Week low 2.07
52-Week high 7.12
Beta -
50-Day moving average -
200-Day moving average -

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 23 Nov 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.48%
Operating margin -1.45%

Operational effectiveness

Return on assets -0.25%
Return on equity -0.45%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.27
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.88
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 4.72
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 6.98%
Book value per share (mrq) 5.82

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -